Henry N. Ginsberg, MD, is the Irving Professor of Medicine at Columbia University College of Physicians and Surgeons, Associate Dean for Clinical and Translational Research, and Director of the Irving Institute for Clinical and Translational Research at Columbia University Medical Center in New York, New York.  He is the Principal Investigator of one of the first 12 NIH–funded Clinical Translational Science Awards (CTSA). Dr. Ginsberg is also principal investigator on two R01 research grants from the NIH, National Heart, Lung, and Blood Institute.  He is also the co-principal investigator at Columbia on the ACCORD Trial.  His research interests have focused on the regulation of plasma cholesterol and triglyceride blood levels, particularly the metabolism of apolipoprotein B–containing lipoproteins in cells, mice, and humans. He has authored or coauthored more than 200 articles, reviews, and chapters related to lipids, diabetes, and heart disease.